We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00780884
Recruitment Status : Completed
First Posted : October 28, 2008
Last Update Posted : June 23, 2015
Information provided by (Responsible Party):
HaEmek Medical Center, Israel

October 26, 2008
October 28, 2008
June 23, 2015
April 2008
April 2009   (Final data collection date for primary outcome measure)
sleep efficiency [ Time Frame: 8 weeks ]
Same as current
Complete list of historical versions of study NCT00780884 on ClinicalTrials.gov Archive Site
anxiety and depression levels [ Time Frame: 8 weeks ]
Same as current
Not Provided
Not Provided
Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients
Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients
Insomnia, a common feature of schizophrenia, has serious consequences for daytime functioning and quality of life. Although insomnia is most often treated with medication, a growing number of studies have demonstrated the efficiency of a variety of relaxation techniques, cognitive behavioral therapies and alternative medicine procedures. Acupuncture is among the oldest healing practices in the world. Part of traditional Chinese medicine, acupuncture aims to restore and maintain health through the stimulation of specific points on the body. Previous studies have demonstrated that acupuncture has a positive influence on a number of diseases and disorders, among them Depression, Chronic Pain and Sleep Disorders. Hence, the aim of the present study is to examine the effects of acupuncture as a treatment for insomnia in schizophrenic patients.The study begins with a 7-day, running-in, no-treatment period, followes by an 8-week experimental period. During the experimental period, subjects receive acupuncture treatments twice a week. During the first week of the study (no-treatment period) and the last week of the experimental period, subjects' sleep is monitored with a wrist actigraph, and subjects complete a wide spectrum of questionnaires.
Not Provided
Not Provided
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Schizophrenia
  • Schizoaffective
Device: acupuncture
16 sessions of acupuncture treatment, twice a week.
Experimental: acupuncture needles
Acupuncture needles named acuzone needles. The acuzone needles are sterile and single use, manufactured by DONG BANG MEDICAL CO.,LTD.
Intervention: Device: acupuncture
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
April 2009
April 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. schizophrenia or schizoaffective disorder - diagnosed according DSM-4.
  2. capability to sign inform consent.

Exclusion Criteria:

  1. unstable physical illness
  2. drug or alchohol abuse or dependence
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
HaEmek Medical Center, Israel
HaEmek Medical Center, Israel
Not Provided
Principal Investigator: Ilana Kremer, MD Haemek Mediacl Center
HaEmek Medical Center, Israel
June 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP